Literature DB >> 1256070

Clinical observations on thyrotoxicosis coexisting with myotonic dystrophy.

D M Peterson, J V Bounds, W E Karnes.   

Abstract

Two cases are presented and a third is cited from the literature in which the onset of hyperthyroidism exacerbated acute weakness in previously undiagnosed myotonic dystrophy. In two of the cases a return to the euthyroid state after treatment was associated with marked clinical improvement in muscle weakness. In the third case, severe bulbar and respiratory muscle weakness, which was apparently aggravated by the thyrotoxicosis, was followed by aspiration pneumonitis and death. Possible mechanisms for the effect of excessive thyroxine on muscle function are reviewed. Early diagnosis and aggressive treatment of the hyperthyroidism is extremely important.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1256070

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  Endocrine function in 97 patients with myotonic dystrophy type 1.

Authors:  M C Ørngreen; P Arlien-Søborg; M Duno; J M Hertz; J Vissing
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

2.  Effect of hyperthyroidism on the contractile and histochemical properties of fast and slow twitch skeletal muscle in the rat.

Authors:  C J Nicol; D S Bruce
Journal:  Pflugers Arch       Date:  1981-04       Impact factor: 3.657

3.  Primary Hyperparathyroidism and Hyperthyroidism in a Patient with Myotonic Dystrophy: A Case Report and Review of the Literature.

Authors:  Yosra Cherif; Baha Zantour; Wafa Alaya; Olfa Berriche; Samia Younes; Mohamed Habib Sfar
Journal:  Case Rep Endocrinol       Date:  2015-06-15

4.  Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3.

Authors:  Raffaele Ambrosio; Valentina Damiano; Annarita Sibilio; Maria Angela De Stefano; Vittorio Enrico Avvedimento; Domenico Salvatore; Monica Dentice
Journal:  Nucleic Acids Res       Date:  2013-02-08       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.